University of California, Irvine; MDA ALS and Neuromuscular Center, — Orange, California

University of California, Irvine; MDA ALS and Neuromuscular Center, is a clinical research site located in Orange, California, United States 92868.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

University of California, Irvine; MDA ALS and Neuromuscular Center, has participated in 1 clinical trials.

Therapeutic areas: Amyotrophic Lateral Sclerosis.

Sponsors: Sangamo Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Orange

Browse all research sites in California · View every site in Orange

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California, Irvine; MDA ALS and Neuromuscular Center,?

University of California, Irvine; MDA ALS and Neuromuscular Center, has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California, Irvine; MDA ALS and Neuromuscular Center, conducted?

University of California, Irvine; MDA ALS and Neuromuscular Center, has 1 clinical trials on record. Their work covers Amyotrophic Lateral Sclerosis.

Is University of California, Irvine; MDA ALS and Neuromuscular Center, accredited by Crixeo Clinical Trials?

University of California, Irvine; MDA ALS and Neuromuscular Center, has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California, Irvine; MDA ALS and Neuromuscular Center,?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.